Janus Capital Group

Janus provides growth and risk-managed investment strategies and manages equity, fixed income, money market, and balanced mutual funds.

Business Model:

Revenue: $1.4B

Employees: 1,001-5,000

Rankings

Detailed Janus Capital Group Information

Geographic Data

Janus Capital Group headquarters map

Address: 151 Detroit St

City: Denver

State: CO

Zip: 80206

Country: US

Financial Info

Stage:

Raised Last:

$0

Raised Total:

$0

Metrics

0Website Global Rank

0Website Monthly Traffic

Twitter Followers

Description

Janus Capital Group is a global investment management firm managing $160 billion in global assets through product offerings across growth, mathematical, value and fixed-income. They work hard, think smart, and exist to create success for their clients.

Contact Phone:
+13033333863

Contact Email:

Janus Capital Group went public on 7/7/2000 on the NYSE

Listed Exchange:
NYSE

IPO Date:
7/7/2000

Ticker Symbol:
JNS

Live

Opened: -/share

EBITDA -
Total Cash -
Total Debt -
Total Revenue -
Total Profit (Gross) -
PE Ratio -
Announced Date Company Transaction Money Raised
1/2015 Aduro BioTech Series D 51.4M
6/2000 Plumtree Software Venture Round 23M
5/2013 Apptio Series E 45M
10/2011 Workday Series F 85M
4/2014 Sierra Oncology Series D 0
3/2018 Bigfoot Biomedical Series B 0
7/2017 Silk Road Medical Series C 0
9/2015 Intellia Therapeutics Series B 0
7/2008 Portola Pharmaceuticals Series C 60.1M
9/2015 AveXis Series D 65M
6/2015 Clementia Pharmaceuticals Venture Round 0
3/2017 Solid Biosciences Series C 0
12/2015 Lyft Series F 0
6/2014 Okta Series E 75M
2/2021 Highview Power Corporate Round -
4/2015 Edge Therapeutics Series C 56M
5/2015 REGENXBIO Series D 0
6/2006 MediQuest Therapeutics Series A 0
2/2021 Highview Power Corporate Round -
3/2018 Bigfoot Biomedical Series B 0
7/2017 Silk Road Medical Series C 0
3/2017 Solid Biosciences Series C 0
12/2015 Lyft Series F 0
9/2015 AveXis Series D 0
9/2015 Intellia Therapeutics Series B 0
6/2015 Clementia Pharmaceuticals Venture Round 0
5/2015 REGENXBIO Series D 0
4/2015 Edge Therapeutics Series C 0

Startup Industries

Startup Locations

Portfolio Current Status

Portfolio Employee Count

Name Price
Name Size Announced Date

You know, we could be doing all this for you..

CoBee's Logo

Be ahead of your competition

  • Realtime intelligence
  • Automated contact tracking
  • Unmatched insights
  • Eliminate manual research